ATRC-101: A first-in-class engineered fully human monoclonal antibody that targets a tumor-restricted ribonucleoprotein complex Del-alco, J., Emerling, D., Manning-Bog, A., Baia, G., Lippow, S., Scholz, A., Zhu, Y., Cavet, G., Volkmuth, W., Dhawan, I., Benjamin, J., Robinson, W., Serafini, T., Greenberg, N. BMC. 2019

View details for Web of Science ID 000496473200274